Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05283200 · ClinicalTrials.gov registry record · NA
Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy
A NA study of Lifestyle, sponsored by Imad Najm MD.
- Active
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05283200 is a NA study of Lifestyle that is active but no longer recruiting, run by Imad Najm MD. The registered enrollment target is 1,000 participants, above the 73-participant average among 3 other Lifestyle trials with a reported enrollment target (1270% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05283200, a NA study of Lifestyle, is active but no longer recruiting, sponsored by Imad Najm MD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective controlled, randomized study to examine the effects of behavioral and wellness-based interventions on seizure frequency for adult patients with medication resistant epilepsy who are still experiencing 1 or more seizures per month.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Yoga
- BEHAVIORAL Music
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05283200
The ClinicalTrials.gov registry entry for NCT05283200 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 3 other Lifestyle trials with a reported enrollment target (1270% higher). The listed sponsor is Imad Najm MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lifestyle appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT05283200 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05283200 about?
NCT05283200 is a clinical study titled "Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy". A prospective controlled, randomized study to examine the effects of behavioral and wellness-based interventions on seizure frequency for adult patients with medication resistant epilepsy who are still experiencing 1 or more seizures per month.
What is the current status of trial NCT05283200?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-02-11. Estimated completion is 2026-06.
What conditions does trial NCT05283200 study?
This clinical trial studies the following conditions: Lifestyle.
What interventions are being tested in trial NCT05283200?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Yoga (BEHAVIORAL), Music (BEHAVIORAL).
Who is sponsoring clinical trial NCT05283200?
This trial is sponsored by Imad Najm MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05283200 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lifestyle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.